Sepsis — Early Recognition & Management

Key Points

• Sepsis is a clinical syndrome of infection-associated organ dysfunction; no single biomarker or score confirms or excludes it.
• Use lactate as a severity and perfusion marker, but interpret it in clinical context.
• Obtain blood cultures promptly and ideally before antibiotics if doing so does not delay therapy.
• Give immediate antimicrobials for septic shock and probable or definite sepsis; possible sepsis without shock can undergo a rapid diagnostic assessment first.
• For sepsis-induced hypoperfusion or shock, use crystalloids with frequent reassessment rather than an uncritical fixed-volume approach.
• Norepinephrine is the preferred first-line vasopressor; an initial MAP target near 65 mm Hg is appropriate for most adults.
• Identify conditions requiring source control early, including abscess, obstructed infected urinary tract, ischemic or perforated bowel, infected device, and necrotizing infection.
• De-escalate antimicrobials and remove excess fluid when clinically appropriate after the acute resuscitation phase.

Algorithm

1. Recognize suspected infection plus new organ dysfunction; activate a sepsis pathway or bedside huddle when appropriate.
2. Stabilize airway and breathing, provide oxygen or ventilation as required, place monitors, and obtain IV or intraosseous access.
3. Draw lactate, blood cultures, CBC, metabolic panel, coagulation studies, and source-directed tests without creating harmful treatment delays.
4. Classify the likelihood of infection and the presence or absence of shock; begin antimicrobials according to urgency and local guidance.
5. For hypoperfusion, give balanced crystalloid in reassessed boluses toward an initial total near 30 mL/kg when appropriate.
6. Start norepinephrine if hypotension persists or earlier when severe shock makes further fluid alone inappropriate; target MAP about 65 mm Hg initially.
7. Obtain source-directed imaging and arrange drainage, debridement, device removal, or other source control when indicated.
8. Reassess perfusion, mentation, capillary refill, urine output, lactate trend, oxygenation, and fluid tolerance; escalate organ support and ICU care as needed.

Clinical Synopsis & Reasoning

Sepsis should be suspected when an acutely ill adult has a plausible infection together with new physiologic or organ dysfunction such as altered mentation, hypoxemia, oliguria, hypotension, thrombocytopenia, coagulopathy, hyperbilirubinemia, rising creatinine, or elevated lactate. Septic shock is a higher-risk phenotype with circulatory and metabolic abnormalities that persist despite initial fluid resuscitation. The diagnosis remains clinical. A normal lactate does not exclude sepsis, and an elevated lactate is not specific for infection. Current guidance favors NEWS, NEWS2, MEWS, or SIRS over qSOFA when a single screening tool is used, while emphasizing that no screening score should replace bedside assessment. The initial evaluation should identify the likely source, determine the severity of organ dysfunction, and look for diagnoses that mimic sepsis, including hemorrhage, pulmonary embolism, pancreatitis, adrenal crisis, toxicologic syndromes, and cardiogenic shock. Obtain blood cultures promptly and ideally before antibiotics when this does not meaningfully delay treatment. Measure lactate when sepsis is suspected, obtain source-directed cultures, and use imaging based on the suspected focus. Bedside ultrasound can help evaluate ventricular function, pulmonary edema, free fluid, biliary disease, hydronephrosis, and response to a fluid challenge, but static measures of preload alone are poor guides to additional fluid. Reassessment after every major intervention is essential because the hemodynamic phenotype can evolve rapidly.

Treatment Strategy & Disposition

Treat sepsis and septic shock as medical emergencies. Provide oxygen and ventilatory support when needed, establish vascular access, and begin crystalloid resuscitation for sepsis-induced hypoperfusion or shock. The 2026 Surviving Sepsis Campaign suggests at least 30 mL/kg of intravenous crystalloid during the first 3 hours, individualized to the patient and followed by frequent reassessment. Balanced crystalloids are generally preferred over 0.9% saline. Use dynamic findings such as passive leg raise response, stroke volume change, capillary refill, skin perfusion, urine output, bedside ultrasound, and the overall clinical trajectory to decide whether more fluid is likely to help. Start norepinephrine promptly when hypotension persists or when profound shock makes waiting for a large fluid volume unsafe, targeting an initial mean arterial pressure around 65 mm Hg in most adults. Add vasopressin when norepinephrine requirements are escalating and consider epinephrine when pressure remains inadequate. Antimicrobials should be given immediately, ideally within 1 hour, for septic shock and for probable or definite sepsis. In possible sepsis without shock, a rapid time-limited diagnostic assessment is appropriate, with antibiotics within 3 hours if infection remains likely. Choose empiric therapy according to source, local resistance, recent cultures, health care exposures, allergies, and immune status, then narrow or stop therapy as data clarify the diagnosis. Pursue source control as early as feasible, ideally within 6 hours when an intervention is required. Patients requiring vasopressors, invasive ventilation, or close organ support belong in an ICU; lower-risk patients still require structured reassessment because deterioration can be abrupt.

Management Notes

Resuscitation should be iterative rather than a one-time bundle. The initial fluid recommendation is a starting point for patients with hypoperfusion or shock, not permission to continue fluid despite worsening oxygenation, venous congestion, or absent fluid responsiveness. Peripheral norepinephrine can be started through a well-sited proximal IV while definitive access is arranged when waiting would prolong hypotension. Once the patient stabilizes, review all empiric treatments and remove what is no longer needed. Antibiotic spectrum and duration should follow cultures, source control, and clinical response. Consider active de-resuscitation after the shock phase when fluid accumulation is contributing to organ dysfunction. Document the suspected source, severity, antimicrobial timing, perfusion response, source-control plan, and escalation triggers so that transitions between the emergency department, ward, and ICU do not interrupt time-sensitive care.

Epidemiology / Risk Factors

• Sepsis can arise from community-acquired or health care-associated infection and affects every age group, with incidence and mortality increasing with age and comorbidity.
• Common sources include lung, urinary tract, abdomen, skin and soft tissue, biliary tract, and intravascular devices.
• Risk is increased by immunosuppression, malignancy, chronic organ disease, recent surgery or hospitalization, invasive devices, and frailty.
• Culture-negative sepsis is common, so microbiologic confirmation is not required when the clinical syndrome is convincing.
• Delayed recognition, delayed source control, and persistent shock are associated with worse outcomes.

Investigations

Initial Targets

Pharmacology

Prognosis / Complications

• Outcome is strongly influenced by baseline health, number and severity of failing organs, timeliness of effective therapy, and ability to control the infectious source.
• Persistent hyperlactatemia, refractory vasopressor requirement, worsening renal or respiratory failure, and coagulopathy identify higher-risk trajectories.
• Survivors may experience post-sepsis cognitive, functional, psychological, and physical impairment and often need structured follow-up.
• Readmission is common, particularly among older adults and those with chronic disease or unresolved infection risk.
• Early rehabilitation, medication reconciliation, infection prevention, and clear transition planning can reduce post-hospital complications.

Patient Education / Counseling

• Explain that sepsis is a time-sensitive complication of infection and that recurrence or deterioration can happen quickly.
• At discharge, review the treated source, antimicrobial plan, pending cultures, medication changes, and the reason for each follow-up appointment.
• Advise urgent reassessment for recurrent fever with confusion, breathing difficulty, faintness, markedly reduced urine output, rapidly worsening weakness, or inability to maintain hydration.
• Encourage recommended vaccinations, wound and device care, and prompt treatment of recurrent infection in high-risk patients.
• Discuss post-sepsis fatigue, weakness, sleep disturbance, anxiety, and cognitive symptoms so patients and caregivers know when to seek rehabilitation or medical review.

References

1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 — Link